LFCR — LIFECORE BIOMEDICAL, INC. \DE\

Nasdaq · Health Care · Pharmaceuticals · CIK 1005286 ·
Last close
$5.35
Market Cap
$200.68M
52W High
$5.92
52W Low
$3.63
ADV30
192,823
Next earnings
2026-08-05
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities. The company also manufactures and sells pharmaceutical-grade hyaluronic acid in bulk form, as well as for use in formulated and filled syringes and vials for injectable products used in treating various medical conditions and procedures, including ophthalmic and orthopedic applications. In addition, it offers product development services, including analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and materials production for clinical studies. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 23,193,000 4,462,000 -4,672,000 -14,980,000 225,499,000 20,795,000 253,937,000
Sep 2025 31,109,000 7,791,000 -3,067,000 -9,991,000 235,204,000 18,856,000 245,741,000
May 2025 36,444,000 13,982,000 2,899,000 -1,147,000 239,342,000 8,265,000 238,006,000
Feb 2025 35,154,000 9,845,000 -2,293,000 -14,769,000 237,693,000 5,417,000 235,464,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$2,169,000
Investing CF
$-4,730,000
Financing CF
$3,943,000
CapEx
$-11,730,000
Dividends Paid
Buybacks
EPS Diluted TTM
$-1.07
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$-218,095,000
Inventory
$33,801,000
Receivables
$29,133,000
ST Investments
EBIT TTM
$-9,226,000
Pretax Income TTM
$-32,077,000
Interest Exp TTM
$22,851,000
Analysts
3

Yahoo Snapshot (yfinance, live)

Total Revenue
$129,464,592
EBITDA
$8,242,287
Free Cash Flow
Enterprise Value
$384,488,640
Total Cash
$20,795,000
Total Debt
$150,140,992
Shares Out
37,509,407
Trailing EPS
$-1.27
Book Value
$-0.38
ROE
ROA
Div Yield

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 232,177,000 246,379,000
May 2025 128,867,000 -12,006,000 -38,717,000 239,342,000 238,006,000 -206,000
May 2024 128,261,000 -7,188,000 12,013,000 253,960,000 242,645,000 257,000
May 2023 103,269,000 -19,720,000 -99,563,000 253,545,000 257,775,000 -17,441,000
May 2022 111,270,000 -3,432,000 -116,715,000 -22,593,000

TTM Snapshot

Revenues TTM
$124,344,000
NetIncome TTM
$-50,191,000
OpCashFlow TTM
$0
Assets (Latest)
$239,342,000
Forward EPS
$-0.81

Max Pain — expiry 2026-09-18

max pain strike: $5.00 · spot: $5.35 · call oi: 898 · put oi: 390
Expected Move to 2026-09-18: ±$2.05 (38.32%) — implied range $3.30$7.40 · ATM straddle on $5.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
BCYC BICYCLE THERAPEUTICS PLC $202.50M $4.02
KROS Keros Therapeutics, Inc. $198.51M $10.03
ARCT Arcturus Therapeutics Holdings Inc. $202.94M $7.14
NERV Minerva Neurosciences, Inc. $203.59M $4.37
UNCY Unicycive Therapeutics, Inc. $196.41M $7.17

News headlines (Yahoo Finance, 1h cache)

Lifecore Biomedical Signs New Agreement with Global Pharmaceutical Company
2026-06-15 11:05 · Yahoo
Lifecore Biomedical (LFCR) Stock Draws Fresh Price Target Split After FY26 Outlook
2026-06-13 05:06 · Yahoo
Lifecore Biomedical Signs Agreement with New Biopharmaceutical Customer
2026-06-02 11:05 · Yahoo
How The Lifecore Biomedical (LFCR) Narrative Is Shifting On Guidance, Timing And 2028 Expectations
2026-05-29 01:03 · Yahoo
Lifecore Biomedical to Participate in William Blair 46th Annual Growth Stock Conference
2026-05-21 11:05 · Yahoo
Lifecore Biomedical to Participate at CDMO Live Europe
2026-05-12 20:05 · Yahoo
Lifecore Biomedical Q1 Earnings Call Highlights
2026-05-06 13:07 · Yahoo
Lifecore Biomedical Reports Financial Results for the First Quarter Ended March 31, 2026, and Provides Corporate Update
2026-05-06 11:05 · Yahoo
Lifecore Biomedical to Report Financial Results for the First Quarter Ended March 31, 2026, on May 6, 2026
2026-04-29 20:05 · Yahoo
Laughing Water Capital’s Insights on Lifecore Biomedical (LFCR)
2026-04-27 11:47 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.